Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2007;115:1866-1875
Published online before print March 26, 2007, doi: 10.1161/CIRCULATIONAHA.106.659730
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
115/14/1866    most recent
CIRCULATIONAHA.106.659730v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zeng, L.
Right arrow Articles by Zhang, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zeng, L.
Right arrow Articles by Zhang, J.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CYCLOSPORIN A
Medline Plus Health Information
*Heart Attack
Related Collections
Right arrow Contractile function
Right arrow Biochemistry and metabolism
Right arrow Chronic ischemic heart disease
Right arrow Animal models of human disease
Right arrow Heart failure - basic studies
Right arrow Myogenesis

(Circulation. 2007;115:1866-1875.)
© 2007 American Heart Association, Inc.


Heart Failure

Bioenergetic and Functional Consequences of Bone Marrow–Derived Multipotent Progenitor Cell Transplantation in Hearts With Postinfarction Left Ventricular Remodeling

Lepeng Zeng, PhD*; Qingsong Hu, MD, MS*; Xiaohong Wang, MD, PhD*; Abdul Mansoor, MD, PhD; Joseph Lee, PhD; Julia Feygin, BS; Ge Zhang, MD, PhD; Piradeep Suntharalingam, BS; Sherry Boozer, BS; Abner Mhashilkar, PhD; Carmelo J. Panetta, MD; Cory Swingen, PhD; Robert Deans, PhD; Arthur H.L. From, MD; Robert J. Bache, MD; Catherine M. Verfaillie, MD; Jianyi Zhang, MD, PhD

From the Department of Medicine (L.Z., Q.H., X.W., A. Mansoor, J.L., J.F., G.Z., C.J.P., C.S., A.H.L.F., R.J.B., J.Z.) and Stem Cell Institute (L.Z., C.M.V.), University of Minnesota Medical School, Minneapolis, Minn; and Athersys, Inc (P.S., S.B., A. Mhashilkar, R.D.), Cleveland, Ohio.

Correspondence to Jianyi Zhang, MD, PhD, University of Minnesota Health Science Center, Mayo Mail Code 508, 420 Delaware St SE, Minneapolis, MN 55455. E-mail zhang047{at}umn.edu

Received August 31, 2006; accepted February 9, 2007.

Background— The present study examined whether transplantation of adherent bone marrow–derived stem cells, termed pMultistem, induces neovascularization and cardiomyocyte regeneration that stabilizes bioenergetic and contractile function in the infarct zone and border zone (BZ) after coronary artery occlusion.

Methods and Results— Permanent left anterior descending artery occlusion in swine caused left ventricular remodeling with a decrease of ejection fraction from 55±5.6% to 30±5.4% (magnetic resonance imaging). Four weeks after left anterior descending artery occlusion, BZ myocardium demonstrated profound bioenergetic abnormalities, with a marked decrease in subendocardial phosphocreatine/ATP (31P magnetic resonance spectroscopy; 1.06±0.30 in infarcted hearts [n=9] versus 1.90±0.15 in normal hearts [n=8; P<0.01]). This abnormality was significantly improved by transplantation of allogeneic pMultistem cells (subendocardial phosphocreatine/ATP to 1.34±0.29; n=7; P<0.05). The BZ protein expression of creatine kinase–mt and creatine kinase–m isoforms was significantly reduced in infarcted hearts but recovered significantly in response to cell transplantation. MRI demonstrated that the infarct zone systolic thickening fraction improved significantly from systolic "bulging" in untreated animals with myocardial infarction to active thickening (19.7±9.8%, P<0.01), whereas the left ventricular ejection fraction improved to 42.0±6.5% (P<0.05 versus myocardial infarction). Only 0.35±0.05% donor cells could be detected 4 weeks after left anterior descending artery ligation, independent of cell transplantation with or without immunosuppression with cyclosporine A (with cyclosporine A, n=6; no cyclosporine A, n=7). The fraction of grafted cells that acquired an endothelial or cardiomyocyte phenotype was 3% and {approx}2%, respectively. Patchy spared myocytes in the infarct zone were found only in pMultistem transplanted hearts. Vascular density was significantly higher in both BZ and infarct zone of cell-treated hearts than in untreated myocardial infarction hearts (P<0.05).

Conclusions— Thus, allogeneic pMultistem improved BZ energetics, regional contractile performance, and global left ventricular ejection fraction. These improvements may have resulted from paracrine effects that include increased vascular density in the BZ and spared myocytes in the infarct zone.


 

CLINICAL PERSPECTIVE




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. Feygin, A. Mansoor, P. Eckman, C. Swingen, and J. Zhang
Functional and bioenergetic modulations in the infarct border zone following autologous mesenchymal stem cell transplantation
Am J Physiol Heart Circ Physiol, September 1, 2007; 293(3): H1772 - H1780.
[Abstract] [Full Text] [PDF]